Psychosomatic renewal of health care

Panminerva Medica

Volumn 52, Issue 3, 2010, Pages 239-248

  Fava, G A ^a,b   Offidani, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Depression; Illness behavior; Life change events; Psychosomatic medicine

Indexed keywords

COMORBIDITY; HEALTH CARE DELIVERY; HUMAN; MENTAL DISEASE; PSYCHOSOMATICS; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SOCIAL SUPPORT;

COMORBIDITY; DELIVERY OF HEALTH CARE; HUMANS; MENTAL DISORDERS; PSYCHOSOMATIC MEDICINE; PSYCHOTHERAPY; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 79952066992     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Tinetti ME, Fried T. The end of the disease era. Am J Med 2004;116:179-85. (Pubitemid 38121675)
2. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of diseasespecific guidelines for patients with multiple conditions. N Engl J Med 2004;351:2870-4.
3. Lipowski ZJ. Psychosomatic medicine: past and present. Can J Psychiatry 1986;31:2-21.
4. Halliday JL. Psychosocial medicine. A study of the sick society. London: Heinemann; 1948
5. Engel GL. The concept of psychosomatic disorder. J Psychosom Res 1967;11:3-9.
6. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36. (Pubitemid 8067676)
7. Fava GA, Sonino N. The biopsychosocial model thirty years later: Psychother Psychosom 2008;77:1-2.
8. Sternberg EM. Emotions and disease: from balance of humors to balance of molecules. Nat Med 1997;3:264-7. (Pubitemid 27112915)
9. Ader R, Cohen N, Feiten D. Psychoneuroimmunology:interacti ons between the nervous system and the immune system. Lancet 1995;354:99-103
10. Kissen DM. The significance of syndrome shift and late syndrome association in psychosomatic medicine. J Nerv Ment Dis 1963;136:34-42.
11. Fassino S, Fava GA, Abbate Daga G, Leombruni P (eds). Psychosomatic Innovations for a new quality of health care. Panminerva Med 2009;51 (suppl.1-3):l-135.
12. Fava GA, Sonino N. The clinical domains of psychosomatic medicine. J Clin Psychiatry 2005;66:849-58. (Pubitemid 41032826)
13. McEwen BS. Physiology and neurobiology of stress and adaptationxentral role of the brain. Physiol Rev 2007;87:873-904. (Pubitemid 47086281)
14. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, De Chant HK et al. Clinical characteristics of women with a history of childhood abuse. JAMA 1997;277:1362-8. (Pubitemid 27194946)
15. Walker EA, Gelfand A, Katon WJ, Koss MP, Von Korff M, Bernstein D et al. Adult health status of women with histories of childhood abuse and neglect. Am J Med 1999;107:332-9.
16. Romans S, Cohen M. Unexplained and underpowered:the relationship between psychosomatic disorders and interpersonal abuse. Harv Rev Psychiatry 2008;16:35-44.
17. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993;153:2093-101.
18. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217. (Pubitemid 29196806)
19. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N. Clinical assessmento of allostatic load and clinimetric criteria. Psychother Psychosom 2010;79:280-4.
20. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States. JAMA 2004;291:1238-45. (Pubitemid 38541668)
21. Rose G. Sick individuals and sick populations. In J Epidemiol 1985;14:32-8. (Pubitemid 15109489)
22. Green LA, Cifuentes M, Glasgow RE, Stange KC. Redesigning primary care practice to incorporate health behavior change. Am J Prev Med 2008;35(5Suppl):347-59.
23. Daniels SR, Greer FR. Committee on Nutrition, Lipid screening and cardiovascular Health in childhood. Pediatrics 2008;122:198-8.
24. World Health Organization. World Health Organization constitution. Geneva: World Health Organization; 1948. p. 28.
25. Ryff CD, Singer B. Psychological well-being. Psychother Psychosom 1996;65:14-23.
26. Chida Y, Steptoe A. Positive psychological well-being and mortality. Psychosom Med 2008;70:741-56.
27. Eriksson M, Lindstrom B. Antonovsky's sense of coherence scale and the relation with health:a systematic review. J Epidemiol Community Health 2006;60:376-81.
28. Hafen BQ, Jarren KM, Frandsen KJ, Smith NL. Mind/body health. Boston: Allyn and Bacon; 1996.
29. Grabe HJ, Frommer J, Ankerhold A, Ulrich C, Groger R, Franke GH et al. Alexithymia and outcome in psychotherapy. Psychother Psychosom 2008;77:189-94.
30. Mischel W, Shoda Y. A cognitive-affective system theory of personality. Psychol Rev 1995;102:246-68.
31. Lipkin M. The medical interview. Ann Intern Med 1984; 100:277-84.
32. Feinstein AR:Clinimetrics. New Haven:Yale University Press; 1987.
33. Fava GA, Ruini C, Rafanelli C. Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73:145-8. (Pubitemid 38437717)
34. Emmelkamp PMG. The additional value of clinimetrics needs to be established rather than assumed. Psychother Psychosom 2004;73:142-4. (Pubitemid 38437716)
35. Schmale AH. Reactions to illness: convalescence and grieving. Psychiat Clin N Am 1979;2:321-30. (Pubitemid 10204425)
36. Sonino N, Fava GA. A simple instrument for assessing stress in clinical practice. Postgrad Med J 1998;74:408-10. (Pubitemid 28331882)
37. Fava GA, Ruini C, Sonino N. Management of recurrent depression in primary care. Psychother Psychosom 2003;72:3-9. (Pubitemid 35478106)
38. Lipowski ZJ. Physical illness, the patient and his environment. In: Reiser MF, editor. American handbook of psychiatry. New York: Basic Books; 1975. pp. 3-42.
39. Lishman WA. Organic psychiatry. The psychological consequences of cerebral disorders. Oxford:Blackwell; 1998.
40. Fava GA, Sonino N. Depression associated with medical illness. CNS Drugs 1996;5:175-89.
41. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-26. (Pubitemid 37270614)
42. Baune BT, Caniato RN, Arolt V, Berger K. The effects of dysthymic disorder on health-related quality of life and disability days in persons with comorbid medical conditions in the general population. Psychother Psychosom 2009;78:161-6.
43. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients:a meta-analysis. Cancer 2009;115:5349-61.
44. Di Matteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000;160:2101-7.
45. Dirmaier J, Watzke B, Koch U, Schulz H, Lehnen H, Pieper L et al. Diabetes in primary care:prospective associations between depression, nonadherence and glycémie control. Psychother Psychosom 2010;79:172-8.
46. Lipowski ZJ. Physical illness and psychopathology. Int J Psychiat Med 1974;5:483-97.
47. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ et al. Depression screening and patient outcomes in cardiovascular care:a systematic review. JAMA 2008;300:2161-71.
48. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease. Psychosom Med 2004;66:802-13. (Pubitemid 39552862)
49. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003;60:627-36. (Pubitemid 36682320)
50. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing's disease. Psychopathology 1998;31:302-6. (Pubitemid 28497657)
51. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81:2647-52. (Pubitemid 26240292)
52. Kellner R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994;61:4-24.
53. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010;72:563-9.
54. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
55. Fava GA. Subclinicalsymptoms inmooddisorders:pathophysiological and therapeutic implications. Psychol Med 1999;29:47-61
56. Fava GA, Sonino N. Psychosomatic assessment. Psychother Psychosom 2009;78:333-41.
57. Fava GA. Irritable mood and physical illness. Stress Med 1987;3:293-9. (Pubitemid 18037043)
58. Lemogne C, Nabi H, Zins M, Cordier S, Ducimetière P, Goldberg M et al.. Hostility may explain the association between depressive mood and mortality:evidence from the French GAZEL cohort study. Psychother Psychosom 2010;79:164-71.
59. Cockram CA Doros G, de Figueiredo JM. Diagnosis and measurement of subjecftive incompetence:the clinical hallmark of demoralization. Psychother Psychosom 2009;78:342-5.
60. Rafanelli C, Roncuzzi R, Milaneschi Y, Tomba E, Colistro MC, Pancaldi LG et al.. Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom 2005;74:179-84. (Pubitemid 41094849)
61. Wise TN, Birket-Smith M. The somatoform disorders for DSMV: the need for change in process and content. Psychosomatics 2002;43:437-40. (Pubitemid 35286050)
62. Watson D, Pennebaker JW. Health complaints, stress and distress:exploring the central role of negative affectivity. Psychol Rev 1989;96:234-54.
63. Porcelli P, Affatati V, Bellomo A, De Carne M, Todarello O, Taylor GJ. Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders. Psychother Psychosom 2004;73:84-91. (Pubitemid 38223751)
64. Rumpf HJ, Lontz W, Vesseler S. A self-administered version of a brief measure of suffering. Psychother Psychosom 2004;73:53-6. (Pubitemid 37524103)
65. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1-8.
66. Wise TN. Diagnostic citeria for psychosomatic research are necessary for DSM-V Psychother Psychosom 2009;76:330-2.
67. Porcelli P, Bellomo A, Quartesan R, Altamura M, luso S, Ciannameo I et al. Psychosocial functioning in consultation-liaison psychiatry patients. Psychother Psychosom 2009;78:352-8.
68. Mechanic D, Volkart EH. Illness behavior and medical diagnosis. J Health Hum Behav 1980;1:86-94.
69. Pilowsky I. Abnormal illness behavior. Chichester: Wiley; 1997.
70. Goldbeck R. Denial in physical illness. J Psychosom Res 1997;43:575-93. (Pubitemid 28134932)
71. Muldoon MF, Barger SD, Flory JD, Manuck SB. What are quality of life measurements measuring? BMJ 1998;316:542-5.
72. Sonino N, Peruzzi P. A psychoneuroendocrinology service. Psychother Psychosom 2009;78:346-51.
73. Porcelli P, Sonino N. Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Basel: Karger; 2007.
74. Fava GA, Fabbri S, Sirri L, Wise TN. Psychological factors affecting medical conditions new proposal for DSM-V Psychosomatics 2007;48:103-11.
75. Kellner R. Somatizatiomthe most costly comorbidity? In: Maser JD, Cloninger CR, editors. Comorbidity of mood and anxiety disorders. American Psychiatric Press; 1990. p. 239-52.
76. Katon WJ, Walker EA. Medically unexplained symptoms in primary care. J Clin Psychiatry 1998;59 (suppl 20): 15-21. (Pubitemid 29001828)
77. Kroenke K, Mangelsdorff D. Common symptoms in ambulatory care. Am J Med 1989;86:262-8.
78. Sobrinho LG. Psychopathology in endocrine disorders. Why so persistent after cure? Psychother Psychosom 2004;73:65-7.
79. Ornish D, Scherwitz LW, Billings JN, Gould KL, Merritt TA, Sparler S et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280:2001-7.
80. Narayan KMV, Kanaya AM, Gregg EW. Lifestyle intervention for the prevention of type 2 diabetes mellitus. Treat Endocrinol 2003;2:315-20. (Pubitemid 37075636)
81. Joosten Ea, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP de Jong CA. Sustematic review oft he effects of shared decision making on patient satisfactionm treatment adherence and health status. Psychother Psychosom 2008;77:219-26. (Pubitemid 351685446)
82. Compas BE, Haagon DA, Keefe FJ, Leitenberg H, Williams DA. Sampling of empirically supported psychological treatments from health psychology:smoking, chronic pain, cancer, and bulimia nervosa. J Consult Clin Psychol 1998;66:89-112. (Pubitemid 28086811)
83. Mayou R, Smith EOP. Hospital doctors' management of psychological problems. Br J Psychiatry 1986;148:194-7. (Pubitemid 16158522)
84. Jackson JL, de Zee K, Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004;140:1054-6.
85. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
86. Ananth J. Psychopharmacological agents in physical disorders. In Fava GA, Freyberger H, eds. Handbook of psychosomatic medicine. Madison, CT:International Universities Press; 1998. p. 593-624.
87. Arnold LM, Keck PE, Welge JIA. Antidepressant treatment of fibromyalgia. Psychosomatics 2000;41:104-13.
88. Balon R. Cognitive-behavioral therapy, psychotherapy and psychosocial interventions in the medically ill. Psychother Psychosom 2009;78:261-4.
89. Classen C, Butler LD, Koopman C,E, Di Miceli S, Giese-Davis J, Fobair P et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer. Arch Gen Psychiatry 2001;58:494-501.
90. Fawzy FI, Canada AL, Fawzy NW. Malignant melanoma. Effects of a brief, stuctured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 2003;60:100-3.
91. Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis. JAMA 1999;281:1304-9. (Pubitemid 29174482)
92. Vos PJ, Garssen B, Visser AP, Duivenvoorden HJ, de Haes HCJM. Psychosocial intervention for women with primary, non-metastic breast cancer. Psychother Psychosom 2004;73:276-85.
93. Smedslund G, Ringdal GI. Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients. J Psychosom Res 2004;57:123-31. (Pubitemid 39296804)
94. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and metaanalysis of clinical trials. Psychother Psychosom 2009;78:265-74.
95. Hartmann M, Bäzner E, Wild B, Eisler I, Herzog W. Effects of interventions involving the family in the treatment of adult patients with chronic physical diseases:a meta-analysis. Psychother Psychosom 2010;79:136-48.
96. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes:a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205-15. (Pubitemid 30413214)
97. Sirri L, Grandi S, Fava GA. The Illness Attitude Scales. Psychother Psychosom 2008;77:337-50.
98. Wise TN. Psychosomatic medicine:an approach needed now more than ever. Int J Clin Practice 2010;64:999-1001.